Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus 18”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00157950
What this trial is testing

Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 176
Testing effectiveness (Phase 2)Study completedNCT00365716
What this trial is testing

Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)

Who this might be right for
Papillomavirus InfectionsGenital Diseases, Female
Merck Sharp & Dohme LLC 1,158
Testing effectiveness (Phase 2)Study completedNCT03180684
What this trial is testing

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Who this might be right for
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)Vulvar DysplasiaVulvar Intraepithelial Neoplasia (VIN)+4 more
Inovio Pharmaceuticals 33
Large-scale testing (Phase 3)Active Not RecruitingNCT06632912
What this trial is testing

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Who this might be right for
Human Papillomavirus (HPV) InfectionHPV (Human Papillomavirus)-Associated Carcinoma
National Vaccine and Serum Institute, China 1,800
Large-scale testing (Phase 3)Active Not RecruitingNCT05662020
What this trial is testing

Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 2,750
Large-scale testing (Phase 3)UnknownNCT05668572
What this trial is testing

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 12,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05056402
What this trial is testing

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 1,382
Early research (Phase 1)Study completedNCT01263327
What this trial is testing

Clinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Who this might be right for
Cervical Cancer
Xiamen University 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06273553
What this trial is testing

A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3

Who this might be right for
Human Papillomavirus Associated Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 2/3Human Papillomavirus Type 16 Infection+1 more
RinuaGene Biotechnology Co., Ltd. 39
Large-scale testing (Phase 3)Study completedNCT03185013
What this trial is testing

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Who this might be right for
Cervical DysplasiaCervical High Grade Squamous Intraepithelial LesionHSIL
Inovio Pharmaceuticals 201
Not applicableStudy completedNCT03206255
What this trial is testing

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 940
Post-approval studies (Phase 4)Study completedNCT03629886
What this trial is testing

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

Who this might be right for
Cervical Intraepithelial Neoplasia
GlaxoSmithKline 6,051
Large-scale testing (Phase 3)UnknownNCT03901690
What this trial is testing

Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study

Who this might be right for
Genital Wart Virus Infection
Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri 102
Large-scale testing (Phase 3)Study completedNCT00122681
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 18,729
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303751
What this trial is testing

Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV

Who this might be right for
HPVHigh-risk HPV (Any Strain)Human Papillomavirus (HPV) Infections
Institut d'Investigació Biomèdica de Bellvitge 80
Testing effectiveness (Phase 2)Study completedNCT01687192
What this trial is testing

Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.

Who this might be right for
TransplantationSystemic Lupus ErythematosusSystemic Immune Disease
University Hospital, Bordeaux 37
Not applicableStudy completedNCT03671369
What this trial is testing

A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

Who this might be right for
Neoplasms, Rectal
GlaxoSmithKline 670
Not applicableUnknownNCT04969445
What this trial is testing

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 647
Large-scale testing (Phase 3)Active Not RecruitingNCT06041061
What this trial is testing

Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years

Who this might be right for
HPV InfectioNHPV-Related Carcinoma
Sinocelltech Ltd. 18,000
Early research (Phase 1)Study completedNCT02379520
What this trial is testing

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus Positive Oropharyngeal CarcinomaHuman Papillomavirus Positive Cervical Carcinoma+3 more
Baylor College of Medicine 32
Next Page